Atlas FDA

UVAR XTS PHOTOPHORESIS SYSTEM

FDA premarket approval P860003/S035 · decided 2000-01-14

Approval details

PMA number
P860003
Supplement
S035
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
UVAR XTS PHOTOPHORESIS SYSTEM
Generic name
System, photopheresis, extracorporeal
Applicant
Therakos Development Limited
Date received
1999-12-20
Decision date
2000-01-14
Days to decision
25 days
Decision code
APPR
Product code
LNR
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Dublin
Statement
Approval is for a new material, Codan Polypropylene RE764F/Cawiton, to be used in the body of the drip chamber of the UVAR XTS System's disposable set.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.